1,948 Shares in Align Technology, Inc. $ALGN Bought by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. purchased a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,948 shares of the medical equipment provider’s stock, valued at approximately $369,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Mather Group LLC. boosted its holdings in shares of Align Technology by 257.9% in the 2nd quarter. Mather Group LLC. now owns 1,564 shares of the medical equipment provider’s stock worth $296,000 after purchasing an additional 1,127 shares in the last quarter. Evanson Asset Management LLC bought a new stake in Align Technology in the 2nd quarter worth approximately $227,000. Ballentine Partners LLC purchased a new stake in Align Technology in the second quarter worth approximately $293,000. Counterpoint Mutual Funds LLC bought a new position in Align Technology during the second quarter valued at approximately $325,000. Finally, Argent Capital Management LLC grew its position in Align Technology by 163.3% during the second quarter. Argent Capital Management LLC now owns 113,417 shares of the medical equipment provider’s stock valued at $21,473,000 after acquiring an additional 70,344 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Insiders Place Their Bets

In other Align Technology news, CEO Joseph M. Hogan acquired 7,576 shares of the business’s stock in a transaction dated Friday, August 1st. The shares were purchased at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the transaction, the chief executive officer owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.66% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ALGN. Piper Sandler lowered their price objective on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a report on Thursday, July 31st. Zacks Research downgraded shares of Align Technology from a “hold” rating to a “strong sell” rating in a research note on Monday, September 1st. Mizuho set a $210.00 price target on shares of Align Technology in a research report on Thursday, July 31st. Wells Fargo & Company reduced their price objective on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. Finally, Evercore ISI lifted their price objective on Align Technology from $200.00 to $220.00 and gave the stock an “outperform” rating in a report on Wednesday, July 9th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $215.00.

Align Technology Stock Down 2.6%

Shares of Align Technology stock opened at $124.88 on Friday. The company’s fifty day simple moving average is $148.59 and its two-hundred day simple moving average is $167.26. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $259.01. The firm has a market cap of $9.05 billion, a PE ratio of 21.06, a price-to-earnings-growth ratio of 1.44 and a beta of 1.65.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. As a group, sell-side analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has approved a share repurchase program on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.